Proposed OPPS Rule Holds Significant Changes
However, other APC payments drop significantly. Fox example, the proposed APC payment rates for CPT codes assigned to APC 139 could decrease by 31.4%, Shah says. A detailed review of CMS' proposal is required and as always providers should provide comments to CMS.
Separately payable drugs
For CY 2013, CMS proposes to reimburse hospitals for separately payable drugs and biologicals without pass-through status at average sales price (ASP) plus 6%, a 2% increase from 2012.
"I am very excited about this," Shah says. "We have been trying to get CMS to make this change for years, and now the agency has finally included this in its proposed rule." CMS' proposal for 2013 would finally result in payment parity for separately payable drugs in the physician office setting, which is something that providers have been pushing the agency to do. CMS is able to provide payment at the level of ASP +6% by statute if it believes that it does not have average acquisition cost data for separately payable drugs, and though the agency hasn't relied on this argument or the statute in the past, it appears to be doing so for 2013.
- EHR Systems 'Immature, Costly,' AMA Says
- Better HCAHPS Scores Protect Revenue
- Anthem Blue Cross, 7 CA Health Systems Create New Challenger, Business Model
- Narrow Networks Cut Costs, Not Quality, Economists Say
- Interstate Medical Licensure Effort Advances
- CEO Exchange: Preparing for Population Health
- How to Build a Health Plan from Scratch
- Data Points to Boom in Private HIX
- 'Early Offer' Malpractice Programs May Spur Reform
- Insurers see cost hikes in Partners HealthCare (MA) mergers